Journal Articles (Review Article) World Academy of Sciences Journal Year : 2023

Biological applications of imiquimod analogues: An update (Review)

Abstract

The last decade witnessed intensive efforts in drug discovery and the emergence of thousands of molecules with potential for use as therapeutic targets. However, only a few hundred of these molecules reached the stage of clinical trials, with only a handful being translated from the bench to bedside. One such example is imiquimod, an immune response modifier belonging to the imidazoquinoline family. Imiquimod was first approved by the US Food and Drug Administration for the topical treatment of anal and genital warts and actinic keratosis, and later exhibited a potent antitumor activity. This promising activity inspired the development of several imidazoquinoxaline analogues and derivatives. The present review provides a comprehensive overview of the scientific literature on the chemical synthesis of imiquimod and several of its analogues, namely EAPB0203, EAPB0503 and EABP02303. The present review also discusses their preclinical properties and mechanisms of action in the context of cancer and parasitic infections, highlighting the worthiness of translating these activities into therapeutic drugs.
Fichier principal
Vignette du fichier
wasj_5_3_197_PDF.pdf (3.49 Mo) Télécharger le fichier
Origin Publisher files allowed on an open archive
Licence

Dates and versions

hal-04826886 , version 1 (09-12-2024)

Licence

Identifiers

Cite

Joelle Obeid, Abdullah Shaito, Hiba El Hajj, Carine Deleuze-Masquéfa, Pierre-Antoine Bonnet, et al.. Biological applications of imiquimod analogues: An update (Review). World Academy of Sciences Journal, 2023, 5 (3), pp.20. ⟨10.3892/wasj.2023.197⟩. ⟨hal-04826886⟩
34 View
0 Download

Altmetric

Share

More